Adaptive immunity in teleosts: cellular immunity.

Dev Biol (Basel)

Scottish Fish Immunology Research Centre, University of Aberdeen, Aberdeen, Scotland, UK.

Published: August 2005

Specific cell-mediated immunity in fish is to date a relatively poorly studied area in fish immunology. Despite breakthroughs in the cloning of the fish TcR and major histocompatibility (MHC) molecules, and more recently the CD3 and CD8 marker molecules, assays to measure specific T-cell responses are still in their infancy. The classical division of T cells into cytotoxic (Tc) and helper (Th) subpopulations is probably relevant to fish, based on the presence of these functional activities and MHC class I and II molecules, but as yet even this is not definitively proved. This review will consider which specific cell-mediated responses can be measured within fish and what their relevance is to fish vaccination programmes.

Download full-text PDF

Source

Publication Analysis

Top Keywords

specific cell-mediated
8
fish
6
adaptive immunity
4
immunity teleosts
4
teleosts cellular
4
cellular immunity
4
immunity specific
4
cell-mediated immunity
4
immunity fish
4
fish studied
4

Similar Publications

Mechanisms related to tumor evasion from NK cell-mediated immune surveillance remain enigmatic. Dickkopf-1 (DKK1) is a Wnt/β-catenin inhibitor, whose levels correlate with breast cancer progression. We find DKK1 to be expressed by tumor cells and cancer-associated fibroblasts (CAFs) in patient samples and orthotopic breast tumors, and in bone.

View Article and Find Full Text PDF

DSCI: a database of synthetic biology components for innate immunity and cell engineering decision-making processes.

Adv Biotechnol (Singap)

September 2024

MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, Guangdong, 510275, China.

Although significant progress of clinical strategy has been made in gene editing and cell engineering in immunotherapy, it is now apparent that design and modification in terms of complex signaling pathways and motifs on medical synthetic biology are still full of challenges. Innate immunity, the first line of host defense against pathogens, is critical for anti-pathogens immune response as well as regulating durable and protective T cell-mediated anti-tumor responses. Here, we introduce DSCI (Database of Synthetic Biology Components for Innate Immunity, https://dsci.

View Article and Find Full Text PDF

Background: HCV genotypes are 30-35% polymorphic at the nucleotide level, while subtypes within the same genotype differ by nearly 20%. Although previous studies have shown the immune escape potential of several mutations within the HCV proteins, little is known about the effect of genotype/subtype-specific gene polymorphism on T-cell immunity. Therefore, this study employed several methods to examine the impact of genotype/subtype-specific polymorphisms in Core, NS3, NS5A, and NS5B sequences on T cell epitope processing and HLA-epitope interactions.

View Article and Find Full Text PDF

CAN-2409 is a replication-defective adenovirus that delivers the herpes simplex virus (HSV)-thymidine kinase gene to infected cells. Intratumoral administration of CAN-2409 followed by prodrug results in the formation of a toxic metabolite able to induce immunogenic cell death, exposure of tumor-associated antigens, and activation of local and systemic immune responses. We used a dynamic labeling model with MC38 tumor cells implanted in photoconvertible Kaede mice.

View Article and Find Full Text PDF

Arginase-1-specific T cells target and modulate tumor-associated macrophages.

J Immunother Cancer

January 2025

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark

Background: Arginase-1 (Arg1) expressing tumor-associated macrophages (TAMs) may create an immune-suppressive tumor microenvironment (TME), which is a significant challenge for cancer immunotherapy. We previously reported the existence of Arg1-specific memory T cells among peripheral blood mononuclear cells (PBMCs) and described that Arg-1-based immune modulatory vaccines (IMVs) control tumor growth and alter the M1/M2 macrophage ratio in murine models of cancer. In the present study, we investigated how Arg1-specific T cells can directly target TAMs and influence their polarization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!